New drug improves heart function by removing free radicals

April 28, 2001

WINSTON-SALEM, N.C. - A new drug being studied at Wake Forest University Baptist Medical Center has been shown to improve heart function following a heart attack, according to researchers speaking at the American Academy of Pediatrics in Baltimore.

The drug, called M40403, removes free radicals from injured tissues, which can cause extensive damage to the heart following a heart attack. M40403 administered after a heart attack, but prior to re-opening the blood vessels in the heart, appears to protect the heart cells from further damage. In laboratory rats, the drug has been shown to be highly protective against injury from free radicals, according to R. Mark Payne, M.D. associate professor of pediatric cardiology at Wake Forest University School of Medicine and principal investigator of the study.

"The applications of this research are enormous," Payne said. "The early animal studies are very positive. More animal studies need to be completed before we can move to Phase I clinical trials, but I am optimistic. These data support our hypothesis that tissue can be protected during a heart attack, with potentially improved cardiac functioning."

When a person has a heart attack, blood flow to the heart and other organs is stopped. Doctors must quickly reestablish blood flow by opening up the damaged blood vessels, providing needed blood to the heart and other organs in the body. When the blood flow is reestablished, those tissues, which have a fresh inflow of blood, produce a large excess of dangerous free radicals, which damage proteins and DNA in the cell, causing the tissue to die.

Dead tissue later results in scar tissue in the heart, according to Payne. If the drug is administered before the blood vessels in the heart have been reopened - the period in which most of the cardiac damage occurs - then cardiac tissue may be saved with a better long-term outlook for the patient. "Normally these cells have coping mechanisms to deal with free radicals that are generated within the cells in low amounts," he said. "But when the heart has suffered an attack, the cells become overwhelmed and cannot cope with the enormous burst of free radicals that are produced when blood flow is reestablished to the injured regions of the heart. As a result, the cells die and are replaced by scar tissue, which does not function as normal heart muscle."

The drug, of which M40403 is the prototype, protects the cells in the heart from free radical damage, limiting the amount of injury and scar tissue.

"This synthetic drug is much smaller in size than naturally occurring proteins that usually remove free radicals," Payne said. "The small size is very important because it allows the drug to penetrate into tissues, such as the brain and the heart, that larger synthetic drugs and proteins cannot easily penetrate. In other studies, this drug has been shown effective in decreasing stroke injury in laboratory animals, when administered prior to the onset of the stroke. These data are exciting because they suggest a role for these drugs in the early treatment of stroke."

Free radicals have been talked about frequently in the last few years, Payne said. "Many people take doses of vitamins A, C, and E, which can bind to free radicals in the body and remove them," he said. "The unique thing about this drug is that it removes the free radicals from the body, but stays behind to neutralize more."

More studies need to be conducted to study the efficacy of the drug if it were administered after the opening of the blood vessels, instead of prior to opening them up.

Researchers studied M40403 in rats over a period of about one year. Half the rats were given the drug and half were used as a control group. The half who were administered the drug showed less damage to the heart than the control group.

If the studies continue to remain positive, Phase I clinical trails on the drug could begin in about a year, according to Payne.
-end-
MetaPhore Pharmaceuticals, based in St. Louis, M.O., manufactures M40403. In addition to Payne, Daniela Salvemini, Ph.D., with MetaPhore Pharmaceuticals, participated in the study. The National Institutes of Health and the Brenner Center for Child and Adolescent Health funded the study.

Media Contact: Rae Beasley, 336-716-6878.

Wake Forest Baptist Medical Center

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.